The Promise of Biosimilars
Frankly Speaking About Cancer with the Cancer Support Community
In 2010, the Biologics Price Competition and Innovation Act signed into law by President Barack Obama as part of the Affordable Care Act, aimed to promote the development of biological products and create competition, with the goals of increasing treatment options and reducing health care costs. Listen Now
